Case Report: rTMS in Combination with Aripiprazole and Sodium Valproate for the Maintenance Treatment of Rapid Cycling Bipolar Disorder

SOURCE: Frontiers in Psychiatry. 14 (no pagination), 2023. Article Number: 1070046.

DATE OF PUBLICATION: 2023.

AUTHOR: Tao S.; Chen B.; Xu X.; Hu S.; Lu J.

ABSTRACT: As a safe neuromodulation therapy, rTMS is applied to treat a variety of psychiatric and neurological disorders. Additionally, both aripiprazole and sodium valproate are effective in the treatment of rapid cycling bipolar disorder. This case reports a female patient with a 17-year history of bipolar disorder who developed rapid-circulation bipolar disorder 5 years prior to presentation. After combined treatment with rTMS, aripiprazole, and sodium valproate, the patient’s mood remained stable and she was able to live and work normally.

LINK TO FULL ARTICLE: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10060647/